USB459408I5 - - Google Patents

Info

Publication number
USB459408I5
USB459408I5 US45940874A USB459408I5 US B459408 I5 USB459408 I5 US B459408I5 US 45940874 A US45940874 A US 45940874A US B459408 I5 USB459408 I5 US B459408I5
Authority
US
United States
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to US05/633,601 priority Critical patent/US4045571A/en
Publication of USB459408I5 publication Critical patent/USB459408I5/en
Application granted granted Critical
Publication of US4018890A publication Critical patent/US4018890A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
US05/459,408 1973-04-17 1974-04-09 Pyrazol-5-one pharmaceutical compositions and methods for effecting diuresis, saluresis and for treating hypertension Expired - Lifetime US4018890A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US05/633,601 US4045571A (en) 1973-04-17 1975-11-20 Pyrazol-5-ones

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DT2319278 1973-04-17
DE2319278A DE2319278C2 (en) 1973-04-17 1973-04-17 Pharmaceutical agent

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US05/633,601 Division US4045571A (en) 1973-04-17 1975-11-20 Pyrazol-5-ones
US05633636 Division 1975-11-30

Publications (2)

Publication Number Publication Date
USB459408I5 true USB459408I5 (en) 1976-03-23
US4018890A US4018890A (en) 1977-04-19

Family

ID=5878313

Family Applications (2)

Application Number Title Priority Date Filing Date
US05/459,408 Expired - Lifetime US4018890A (en) 1973-04-17 1974-04-09 Pyrazol-5-one pharmaceutical compositions and methods for effecting diuresis, saluresis and for treating hypertension
US06/102,840 Expired - Lifetime US4288446A (en) 1973-04-17 1979-12-12 Pyrazol-5-ones

Family Applications After (1)

Application Number Title Priority Date Filing Date
US06/102,840 Expired - Lifetime US4288446A (en) 1973-04-17 1979-12-12 Pyrazol-5-ones

Country Status (11)

Country Link
US (2) US4018890A (en)
BE (1) BE813745A (en)
DE (1) DE2319278C2 (en)
FR (1) FR2226169B1 (en)
GB (1) GB1434171A (en)
IE (1) IE39211B1 (en)
IL (1) IL44625A (en)
LU (1) LU69870A1 (en)
NL (1) NL178564C (en)
PH (1) PH10818A (en)
ZA (1) ZA742383B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053621A (en) 1974-06-06 1977-10-11 Bayer Aktiengesellschaft 1-[2-(βNaphthyloxy)ethyl]-3-methylpyrazolone-(5) and antithrombotic and antithrombolytic compositions and methods utilizing them

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1229553A (en) * 1983-05-18 1987-11-24 Edmund Y. Lukevits Pharmaceutical preparation for the treatment of hypertensive disease and myocardial infarction
DE3436383A1 (en) * 1984-10-04 1986-04-10 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING PYRAZOLONE DERIVATIVES
USRE35801E (en) * 1985-05-20 1998-05-19 Mitsubishi Chemical Corporation Prophylactic and therapeutic composition for circulatory disorders and method of treatment
DK169672B1 (en) * 1985-05-20 1995-01-09 Mitsubishi Chem Ind Pharmaceutical preparations containing pyrazolone derivatives as active ingredient and the use of pyrazolone derivatives for the preparation of pharmaceutical preparations
DE3626908A1 (en) * 1986-08-08 1988-02-11 Bayer Ag PARENTERAL SOLUTION
ATE502635T1 (en) 2002-08-19 2011-04-15 Pfizer COMBINATION THERAPY AGAINST HYPERPROLIFERATIVE DISEASES
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
US9573122B2 (en) * 2014-08-29 2017-02-21 Chevron U.S.A. Inc. Small crystal LTL framework type zeolites
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US11248001B2 (en) 2019-01-18 2022-02-15 Astrazeneca Ab PCSK9 inhibitors and methods of use thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147276A (en) * 1964-09-01 Pyrazolones
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
US2476986A (en) * 1949-07-26 Elmobe louis martin
US2476987A (en) * 1949-07-26 S-acyloxy pyrazqles and method foe
GB559919A (en) * 1942-09-07 1944-03-10 Lamson Engineering Co Improvements in and relating to pneumatic tube conveyor systems
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
ZA10401B (en) * 1949-08-22
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
GB779703A (en) * 1953-07-06 1957-07-24 Hoechst Ag Pyrazolone compounds and a process for making them
US2848446A (en) * 1954-02-23 1958-08-19 Saul & Co Azo dyestuffs
DE1003215B (en) * 1954-08-07 1957-02-28 Hoechst Ag Process for the preparation of 1-benzyl-3-methyl-pyrazolone- (5)
US3014916A (en) * 1959-01-22 1961-12-26 May & Baker Ltd Pyrazole derivatives
GB935538A (en) * 1959-04-06 1963-08-28 Stop Motion Devices Corp Stop-motion head for use on knitting machines
GB961037A (en) * 1960-08-23 1964-06-17 Smith & Nephew Pyrazolones and processes for their preparation
NL279140A (en) * 1961-05-31
US3190888A (en) * 1963-08-22 1965-06-22 American Home Prod Aryloxyalkylpyrazole
DE1670529C3 (en) * 1966-07-13 1974-01-10 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Substituted s-triazines
GB1190914A (en) * 1966-09-26 1970-05-06 Agfa Gevaert Nv 2-Pyrazolin-5-Ones and the use thereof as Colour Couplers
FR1558513A (en) * 1968-01-04 1969-02-28
GB1247688A (en) * 1968-02-26 1971-09-29 Agfa Gevaert Monomeric and polymeric 2-pyrazoline-5-one colour couplers
JPS4818858B1 (en) * 1969-04-07 1973-06-08
FR2068413A1 (en) * 1969-10-22 1971-08-27 Synthelabo 1-alkyl-3-alkylamino-5-aryl-pyrazolines hypo-and hypertensives
US3615506A (en) * 1970-02-09 1971-10-26 Eastman Kodak Co Silver halide emulsions containing 3-cyclicamino-5-pyrazolone color couplers
US3694456A (en) * 1970-05-08 1972-09-26 Takeda Chemical Industries Ltd 1-disubstituted aminopyrazoles
FR2101060B1 (en) * 1970-08-14 1974-02-01 Roussel Uclaf
FR2104931B1 (en) * 1970-09-08 1975-01-10 Ferlux
JPS548689B1 (en) * 1970-12-04 1979-04-18
JPS5417772B1 (en) * 1970-12-04 1979-07-03
DE2230792A1 (en) * 1972-06-23 1974-01-17 Bayer Ag 3-AMINO-PYRAZOLONE- (5), METHOD FOR MANUFACTURING AND USING IT AS A MEDICINAL PRODUCT
DE2230675A1 (en) * 1972-06-23 1974-01-10 Bayer Ag DIURETIC AND ANTIHYPERTENSIVE AGENT
AR207445A1 (en) * 1973-04-17 1976-10-08 Bayer Ag PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF PIRAZOLONES- (5) -1-SUBSTITUTED

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053621A (en) 1974-06-06 1977-10-11 Bayer Aktiengesellschaft 1-[2-(βNaphthyloxy)ethyl]-3-methylpyrazolone-(5) and antithrombotic and antithrombolytic compositions and methods utilizing them

Also Published As

Publication number Publication date
FR2226169B1 (en) 1978-07-28
IE39211L (en) 1974-10-17
US4288446A (en) 1981-09-08
PH10818A (en) 1977-09-08
BE813745A (en) 1974-10-16
LU69870A1 (en) 1974-11-21
AU6793474A (en) 1975-10-16
FR2226169A1 (en) 1974-11-15
NL178564C (en) 1986-04-16
IE39211B1 (en) 1978-08-30
DE2319278C2 (en) 1986-02-20
DE2319278A1 (en) 1974-11-07
NL7405114A (en) 1974-10-21
ZA742383B (en) 1975-04-30
IL44625A0 (en) 1974-06-30
NL178564B (en) 1985-11-18
GB1434171A (en) 1976-05-05
IL44625A (en) 1978-07-31
US4018890A (en) 1977-04-19

Similar Documents

Publication Publication Date Title
AU476761B2 (en)
AU465372B2 (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU465453B2 (en)
AU465434B2 (en)
AU471343B2 (en)
AU476714B2 (en)
AU466283B2 (en)
AU476696B2 (en)
AU472848B2 (en)
FR2226170A1 (en)
AU477823B2 (en)
AU471461B2 (en)
AR195948A1 (en)
AU476873B1 (en)
AR197627A1 (en)
AU461342B2 (en)
AU477824B2 (en)
AR196212Q (en)
BG19442A1 (en)
BG21597A3 (en)
AU479504A (en)
AU479496A (en)